This inventor holds 7 USPTO granted patents, plus 1 CIPO patent. Top assignees: Sanofi-Aventis, Sanofi. Active years: 1993-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Labarthe sur Seze, FR (1993)
- Toulouse, FR (2009)
- Labarthe sur Leze, FR (2008 - 2014)
Company Filing History:
Years Active: 1993-2014
Title: The Innovative Contributions of Marie-Francoise Bordes
Introduction
Marie-Francoise Bordes is a notable inventor based in Labarthe sur Leze, France. With a remarkable portfolio of seven patents, she has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that have vital therapeutic applications.
Latest Patents
Among her latest inventions is the patent concerning Imidazo[1,5-a]pyridine derivatives. This invention highlights a method for preparing these compounds and pharmaceutical compositions containing them, along with their therapeutic uses. Another key patent focuses on the use of FGF inhibiting substituted 1,2,3 indolizine derivatives, aimed at preparing medicaments for treating diseases linked to pathological choroidal angiogenesis. The derivatives in this patent correspond to a general formula and represent a significant advancement in the treatment of related ailments.
Career Highlights
Throughout her career, Marie-Francoise Bordes has worked with prominent organizations in the pharmaceutical sector, including Sanofi-Aventis and Sanofi. Her work in these companies has contributed to the development of innovative solutions that address various health challenges.
Collaborations
Marie-Francoise has collaborated with esteemed colleagues such as Alain Badorc and Francoise Bono. These partnerships have enriched her research and fostered advancements in pharmaceutical inventions.
Conclusion
In conclusion, Marie-Francoise Bordes stands out as a prolific inventor in the pharmaceutical field. Her patents reflect her dedication to developing innovative compounds that have the potential to improve medical treatments and patient outcomes. Her collaborations and career achievements continue to inspire future innovations in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

